
PRE Valuation
Prenetics Global Ltd
- Overview
- Forecast
- Valuation
- Earnings
PRE Relative Valuation
PRE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PRE is overvalued; if below, it's undervalued.
Historical Valuation
Prenetics Global Ltd (PRE) is now in the Fair zone, suggesting that its current forward PS ratio of 0.95 is considered Fairly compared with the five-year average of -3.72. The fair price of Prenetics Global Ltd (PRE) is between 2.62 to 14.90 according to relative valuation methord.
Relative Value
Fair Zone
2.62-14.90
Current Price:7.58
Fair
-3.33
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Prenetics Global Ltd. (PRE) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 6.28. The thresholds are as follows: Strongly Undervalued below -93.69, Undervalued between -93.69 and -43.71, Fairly Valued between 56.27 and -43.71, Overvalued between 56.27 and 106.26, and Strongly Overvalued above 106.26. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-1.25
EV/EBIT
Prenetics Global Ltd. (PRE) has a current EV/EBIT of -1.25. The 5-year average EV/EBIT is -9.14. The thresholds are as follows: Strongly Undervalued below -96.70, Undervalued between -96.70 and -52.92, Fairly Valued between 34.64 and -52.92, Overvalued between 34.64 and 78.41, and Strongly Overvalued above 78.41. The current Forward EV/EBIT of -1.25 falls within the Historic Trend Line -Fairly Valued range.
0.95
PS
Prenetics Global Ltd. (PRE) has a current PS of 0.95. The 5-year average PS is 1.32. The thresholds are as follows: Strongly Undervalued below -0.61, Undervalued between -0.61 and 0.36, Fairly Valued between 2.29 and 0.36, Overvalued between 2.29 and 3.25, and Strongly Overvalued above 3.25. The current Forward PS of 0.95 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Prenetics Global Ltd. (PRE) has a current P/OCF of 0.00. The 5-year average P/OCF is -2.52. The thresholds are as follows: Strongly Undervalued below -9.88, Undervalued between -9.88 and -6.20, Fairly Valued between 1.16 and -6.20, Overvalued between 1.16 and 4.84, and Strongly Overvalued above 4.84. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Prenetics Global Ltd. (PRE) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Prenetics Global Ltd (PRE) has a current Price-to-Book (P/B) ratio of 0.61. Compared to its 3-year average P/B ratio of 0.63 , the current P/B ratio is approximately -3.07% higher. Relative to its 5-year average P/B ratio of -0.30, the current P/B ratio is about -302.42% higher. Prenetics Global Ltd (PRE) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -3.31%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -3.17% , the current FCF yield is about -100.00% lower.
0.61
P/B
Median3y
0.63
Median5y
-0.30
0.00
FCF Yield
Median3y
-3.31
Median5y
-3.17
Competitors Valuation Multiple
The average P/S ratio for PRE's competitors is 0.19, providing a benchmark for relative valuation. Prenetics Global Ltd Corp (PRE) exhibits a P/S ratio of 0.95, which is 400.00% above the industry average. Given its robust revenue growth of 169.93%, this premium appears sustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of PRE increased by 72.27% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 6.41M to 17.31M.
The secondary factor is the P/E Change, contributed -42.85%to the performance.
Overall, the performance of PRE in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch

NB
NioCorp Developments Ltd
4.370
USD
+0.46%

GNTA
Genenta Science SPA
3.580
USD
+2.14%

OAKU
Oak Woods Acquisition Corp
11.800
USD
+0.77%

RMTI
Rockwell Medical Inc
1.050
USD
+2.94%

CULP
Culp Inc
3.920
USD
-3.45%

MURA
Mural Oncology PLC
1.820
USD
+3.41%

ICCM
Icecure Medical Ltd
0.892
USD
-0.67%

MGLD
Marygold Companies Inc
0.680
USD
-9.93%

OWLT
Owlet Inc
8.110
USD
+4.51%
FAQ

Is Prenetics Global Ltd (PRE) currently overvalued or undervalued?
Prenetics Global Ltd (PRE) is now in the Fair zone, suggesting that its current forward PS ratio of 0.95 is considered Fairly compared with the five-year average of -3.72. The fair price of Prenetics Global Ltd (PRE) is between 2.62 to 14.90 according to relative valuation methord.

What is Prenetics Global Ltd (PRE) fair value?

How does PRE's valuation metrics compare to the industry average?

What is the current P/B ratio for Prenetics Global Ltd (PRE) as of Aug 19 2025?

What is the current FCF Yield for Prenetics Global Ltd (PRE) as of Aug 19 2025?

What is the current Forward P/E ratio for Prenetics Global Ltd (PRE) as of Aug 19 2025?
